腫瘍微小環境における解糖系が樹状細胞機能と抗腫瘍免疫に及ぼす影響
Bo Zhang1,2,3, Linlin Zhao1,2,3, Huzi Li1,2,3
1Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Frontiers in immunology
|February 25, 2026
まとめ
腫瘍微小環境は代謝ストレスを通じて樹状細胞(DC)を抑制する。DCの代謝フィットネスを回復させることで、抗腫瘍免疫を高め、免疫療法の転帰を改善できる可能性がある。
科学分野:
- 免疫学、がん生物学、代謝研究
背景:
- 樹状細胞(DC)は抗腫瘍免疫に不可欠である。腫瘍微小環境(TME)は代謝的な制約を課し、DC機能を損なう。主要な代謝ストレス因子には、乳酸、低酸素症、アデノシン、脂質が含まれる。
研究 の 目的:
- 腫瘍由来の代謝ストレス因子と内在性のDC代謝プログラムが抗腫瘍免疫にどのように影響するかをレビューする。DCの代謝フィットネスを回復させるための治療戦略を探る。がん治療におけるDC代謝を標的とするためのトランスレーショナルな優先順位を特定する。
主な方法:
- TMEにおけるDC代謝に焦点を当てた文献レビュー。代謝ストレス因子が抗原提示、サイトカイン産生、遊走などのDC機能にどのように影響するかを分析する。サブセット特異的なDCの代謝配線と脆弱性を調べる。
主要な成果:
- 代謝ストレス因子はDCを寛容状態に偏らせ、免疫応答を妨げる。異なるDCサブセット(cDC1、cDC2、pDC)は、独自の代謝プロファイルと脆弱性を示す。新たな戦略には、腫瘍の解糖系の阻害、DC代謝の再配線、免疫代謝産物の調節が含まれる。
結論:
- DC代謝を標的とすることは、TMEを再プログラミングするための有望な戦略である。DCの代謝フィットネスを回復させることで、がん免疫療法の効果を高めることができる。トランスレーショナルな優先順位には、DCの代謝的多様性のマッピングと代謝連動バイオマーカーの開発が含まれる。
さらに関連する動画
10:04Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
1.8K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.2K
関連する概念動画
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
